Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
31.17 USD | -0.76% | -5.20% | -19.99% |
Feb. 12 | Craig-Hallum Adjusts Proto Labs Price Target to $38 From $30, Maintains Hold Rating | MT |
Feb. 09 | Transcript : Proto Labs, Inc., Q4 2023 Earnings Call, Feb 09, 2024 |
Summary
- Overall, and from a short-term perspective, the company presents an interesting fundamental situation.
Strengths
- The company's profit outlook over the next few years is a strong asset.
- For the past year, analysts covering the stock have been revising their EPS expectations upwards in a significant manner.
- For the last 4 months, the company has been enjoying highly positive EPS revisions, which were frequently and significantly raised.
- The average target price set by analysts covering the stock is above current prices and offers a tremendous appreciation potential.
- Over the past four months, analysts' average price target has been revised upwards significantly.
- Consensus analysts have strongly revised their opinion of the company over the past 12 months.
- Considering the small differences between the analysts' various estimates, the group's business visibility is good.
Weaknesses
- According to forecast, a sluggish sales growth is expected for the next fiscal years.
- The company does not generate enough profits, which is an alarming weak point.
- With an expected P/E ratio at 32.49 and 28.04 respectively for both the current and next fiscal years, the company operates with high earnings multiples.
Ratings chart - Surperformance
Chart ESG Refinitiv
Sector: Industrial Machinery & Equipment
1st Jan change | Capi. | Investor Rating | ESG Refinitiv | |
---|---|---|---|---|
-19.99% | 803M | C | ||
+5.62% | 78.45B | A- | ||
+17.34% | 69.87B | B | ||
+15.81% | 36.66B | B- | ||
+10.37% | 30.95B | A | ||
+8.92% | 28.48B | C+ | ||
+5.18% | 27.6B | B- | ||
+9.63% | 27.24B | B+ | ||
+11.12% | 24.41B | B+ | ||
+10.20% | 23.51B | B |
Financials
Valuation
Momentum
Consensus
Business Predictability
Environment
Governance
Controversy
Technical analysis
- Stock Market
- Equities
- PRLB Stock
- Ratings Proto Labs, Inc.